Patent Assignment
Reel/Frame 047972/0664
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives")
Recorded: 2018-12-20
Pages: 4
Assignor
UNIVERSITY OF HEIDELBERG
Executed: 2012-07-23
Assignee
MOLECULAR INSIGHT PHARMACEUTICAL, INC.
160 SECOND STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(3)
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), Their Use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
Application:
15/131,118 →
Publication:
US 2016/0228587
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), Their Use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), Their Use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 1, 2016
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 038760/0147 →
Assignment of Assignor's Interest
Jun 1, 2016
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 038760/0033 →
Assignment of Assignor's Interest
Aug 28, 2018
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046729/0111 →
Assignment of Assignor's Interest
Aug 28, 2018
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 046729/0289 →
Assignment of Assignor's Interest
Aug 29, 2018
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 046737/0135 →
Assignment of Assignor's Interest
Aug 29, 2018
From: KLIEM, HANS-CHRISTIAN
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046969/0540 →
Assignment of Assignor's Interest
Aug 29, 2018
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046732/0661 →
Assignment of Assignor's Interest
Oct 12, 2018
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 047146/0548 →
Assignment of Assignor's Interest
Oct 12, 2018
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 047146/0613 →
Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/114,988 at Reel 047972/Frame 0664
Nov 12, 2019
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 050994/0511 →
Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No 16/038,729 at Reel 047972/Frame 0664
Nov 12, 2019
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 050993/0581 →
Corrective Assignment to Correct the Correct the Assignment Previously Recorded at Reel: 047972 Frame: 0664. Assignor(S) Hereby Confirms the Asignment.
Nov 12, 2019
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 050990/0503 →
Declaration to Correct Assignment Record Following Declaration Recorded on November 12, 2019 in Application No. 16/114,988
Feb 21, 2020
From: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
Reel/Frame 051989/0918 →
Declaration to Correct Assignment Record Following Declaration Recorded on November 12, 2019 in Application No. 15/131,118
Feb 21, 2020
From: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
Reel/Frame 051989/0815 →
Declaration to Correct Assignment Record Following Declaration Recorded on November 12, 2019 in Application No. 16/038,729
Feb 21, 2020
From: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
Reel/Frame 051989/0869 →
Second Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/114,988 at Reel 051989/Frame 0918
Nov 20, 2021
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 058573/0601 →
Second Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 15/131,118 at Reel 051989/Frame 0815
Nov 20, 2021
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 058896/0205 →
Second Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/038,729 at Reel 051989/Frame 0869
Feb 9, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059098/0285 →
Declaration of Brenda Herschbach Jarrell
Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0227 →
Declaration of Brenda Herschbach Jarrell
Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0222 →
Declaration of Brenda Herschbach Jarrell
Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0232 →
Nunc Pro Tunc Assignment
Jun 30, 2023
From: DEUTSCHES KREBSFORSCHUNGSZENTRUM; RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
To: NOVARTIS PHARMA AG
Reel/Frame 064132/0202 →
Assignment of Assignor's Interest
Jun 30, 2023
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 064132/0352 →
Assignment of Assignor's Interest
Aug 3, 2023
From: DEUTSCHES KREBSFORSCHUNGSZENTRUM; RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
To: NOVARTIS PHARMA AG
Reel/Frame 064482/0290 →
Assignment of Assignor's Interest
Aug 3, 2023
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 064482/0485 →